en
Scientific article
Letter
English

Long-term efficacy after switch from protease inhibitor-containing highly active antiretroviral therapy to abacavir, lamivudine, and zidovudine

Published inAIDS, vol. 18, no. 16, p. 2213-2215
Publication date2004-11-05
Keywords
  • Adult
  • Antiretroviral Therapy, Highly Active
  • Dideoxynucleosides / administration & dosage
  • Female
  • Follow-Up Studies
  • HIV Infections / drug therapy
  • HIV Protease Inhibitors / therapeutic use
  • Humans
  • Lamivudine / administration & dosage
  • Male
  • Middle Aged
  • Prospective Studies
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Time Factors
  • Treatment Failure
  • Zidovudine / administration & dosage
Research group
Citation (ISO format)
OPRAVIL, Milos et al. Long-term efficacy after switch from protease inhibitor-containing highly active antiretroviral therapy to abacavir, lamivudine, and zidovudine. In: AIDS, 2004, vol. 18, n° 16, p. 2213–2215. doi: 10.1097/00002030-200411050-00019
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0269-9370
10views
0downloads

Technical informations

Creation01/30/2023 4:08:02 PM
First validation04/09/2024 2:19:44 PM
Update time04/09/2024 2:19:44 PM
Status update04/09/2024 2:19:44 PM
Last indexation05/06/2024 6:21:16 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack